Physiomics Share News (PYC)

Physiomics Information

Buy PYC Shares
Add PYC to Watchlist
Add PYC to Alert

Share Price Information for Physiomics (PYC)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1.35

Bid: 1.20

Ask: 1.50

Change: 0.00 (0.00%)

Spread: 0.30 (25.00%)

Open: 1.35

High: 1.35

Low: 1.35

Prev. Close: 1.35

Last checked at -

IN BRIEF: Physiomics pens further deals with Merck KGaA

Fri, 22nd Oct 2021 13:06

Physiomics PLC - oncology consultant based in Oxford - Secures further deals with existing client Germany's Merck KGaA. Says the two deals are expected to be completed by the end of calendar 2021. "These projects involve simulations of clinical efficacy of drug products in Merck's DNA damage/repair portfolio," Physiomics says.

Current stock price: 6.35 pence, up 4.1% on Friday

Year-to-date change: down 14%

By Eric Cunha; ericcunha@alliancenews.com

More News

3 Mar 2015 13:06

Physiomics Shares Surge As It Gets Contract With Merck

2 Feb 2015 08:40

Physiomics Shares Up As It Terminates Equity Swap Deal Early

12 Nov 2014 13:06

UK MIDDAY BRIEFING: RBS, HSBC Hit With Fines, Barclays Still In Talks

12 Nov 2014 12:02

UK WINNERS & LOSERS: G4S And Tullow Oil Lead FTSE 100 Gainers

12 Nov 2014 10:47

Physiomics Optimistic On Virtual Tumour Platform Interest

4 Nov 2014 12:10

UK MIDDAY BRIEFING: Oil Stocks Down As Oil Price Hits 4-Year Low

4 Nov 2014 11:32

UK WINNERS & LOSERS: Imperial Tobacco Gains As Oil Stocks Slide

4 Nov 2014 08:27

Physiomics Shares Jump On Disclosure Of Merck As Partner

4 Nov 2014 08:21

UK MORNING BRIEFING: Legal & General, Imperial Tobacco Start Strongly

27 Oct 2014 11:11

UK WINNERS & LOSERS: Banks Under Stress After EU Test Results

27 Oct 2014 10:16

Physiomics Extends Collaboration With "Major" Pharmaceutical Company

7 Oct 2014 08:51

Physiomics Launches Web-Based Cardiac Toxicity Prediction Service

14 Aug 2014 15:41

Physiomics wins cancer therapy deal

Biology company Physiomics won a contract with an unidentified drug company on Thursday, boosting its shares by 18.75%. Under the deal, Physiomics will model immune therapy agents for cancer research by the end of the year on a fee-for-service basis. Physiomics' chief executive Mark Shadwick said:

14 Aug 2014 12:20

Physiomics Wins Contract With Undisclosed Pharmaceutical Company

12 Jun 2014 12:24

Physiomics Shares Surge On Diatech Pharmacogenetics Collaboration

LONDON (Alliance News) - Shares in Physiomics PLC surged Thursday, after it said it has signed a head of terms agreement for a new collaboration with Diatech Pharmacogenetics srl. The Oxford-based systems biology company said that, under the terms of the expected collaboration agreement, th

Latest Share Chat

Physiomics Share News (PYC)

Share Price Information for Physiomics (PYC)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Physiomics pens further deals with Merck KGaA

Login to your account

Quickpicks are a member only feature

Login to your account